Trulicity and Hizentra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trulicity (dulaglutide) and Hizentra (human immunoglobulin g). Common drug interactions include sinusitis among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Trulicity and Hizentra. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Trulicity?

Trulicity has active ingredients of dulaglutide. It is often used in weight loss. eHealthMe is studying from 77,529 Trulicity users. Check the latest studies of Trulicity.

What is Hizentra?

Hizentra has active ingredients of human immunoglobulin g. eHealthMe is studying from 23,666 Hizentra users. Check the latest studies of Hizentra.

On Jul, 23, 2026

42 people who take Trulicity and Hizentra together, and have interactions are studied.

Trulicity and Hizentra drug interactions.

What are the common drug interactions of Trulicity and Hizentra, by gender? *:

female:

Sinusitis (inflammation of sinus)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Asthenia (weakness)
Pyrexia (fever)
Arthralgia (joint pain)
Headache (pain in head)
Mobility decreased (ability to move is reduced)
Oral candidiasis (fungal infection of mouth)
Rash
Blindness unilateral

male:

Fatigue (feeling of tiredness)
Balance disorder
Death
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Drug ineffective
Gallbladder disorder
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Sinusitis (inflammation of sinus)

What are the common drug interactions of Trulicity and Hizentra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Platelet count decreased

40-49:

Blood glucose increased
Injection site erythema (redness at injection site)

50-59:

Rash
Arthralgia (joint pain)
Oral candidiasis (fungal infection of mouth)
Malaise (a feeling of general discomfort or uneasiness)
Ulcer
Fatigue (feeling of tiredness)
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Headache (pain in head)
Depression
Drug ineffective

60+:

Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Mobility decreased (ability to move is reduced)
Brain neoplasm (tumour of brain)
Post procedural complication
Sinusitis (inflammation of sinus)
Dehydration (dryness resulting from the removal of water)
Hypotension (abnormally low blood pressure)
Influenza
Loss of consciousness
Pain

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 20 people, 47.62%
High Blood Pressure: 9 people, 21.43%
High Blood Cholesterol: 9 people, 21.43%
Diabetes: 9 people, 21.43%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 9 people, 21.43%
Migraine (headache): 9 people, 21.43%
Insomnia (sleeplessness): 9 people, 21.43%
Immunodeficiency: 9 people, 21.43%
Atrophic Vulvovaginitis (inflammation of the vulva): 8 people, 19.05%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 8 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take Trulicity and Hizentra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously